Latest Insider Transactions at Maia Biotechnology, Inc. (MAIA)
This section provides a real-time view of insider transactions for Maia Biotechnology, Inc. (MAIA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MAIA Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MAIA Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
198
+0.04%
|
$792
$4.48 P/Share
|
|
Mar 01
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
282
+0.04%
|
$1,128
$4.48 P/Share
|
|
Feb 28
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,275
+0.16%
|
$5,100
$4.49 P/Share
|
|
Feb 28
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
1,619
+0.31%
|
$6,476
$4.48 P/Share
|
|
Feb 27
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
219
+0.04%
|
$876
$4.47 P/Share
|
|
Feb 22
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
1,073
+0.21%
|
$4,292
$4.48 P/Share
|
|
Feb 21
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
228
+0.04%
|
$912
$4.49 P/Share
|
|
Feb 17
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
73
+0.01%
|
$292
$4.25 P/Share
|
|
Feb 17
2023
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
50
+0.02%
|
$200
$4.25 P/Share
|
|
Feb 17
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
75
+0.01%
|
$300
$4.25 P/Share
|
|
Feb 17
2023
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
76
+0.03%
|
$304
$4.24 P/Share
|
|
Feb 16
2023
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$40
$4.25 P/Share
|
|
Feb 16
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
62
+0.01%
|
$248
$4.25 P/Share
|
|
Feb 16
2023
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
58
+0.02%
|
$232
$4.25 P/Share
|
|
Feb 16
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$40
$4.25 P/Share
|
|
Feb 15
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$40
$4.25 P/Share
|
|
Feb 15
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
10
+0.0%
|
$40
$4.25 P/Share
|
|
Feb 15
2023
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$40
$4.25 P/Share
|
|
Feb 14
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
198
+0.04%
|
$792
$4.25 P/Share
|
|
Feb 14
2023
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
14
+0.01%
|
$56
$4.25 P/Share
|
|
Feb 10
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
343
+0.04%
|
$1,372
$4.24 P/Share
|
|
Feb 10
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
337
+0.07%
|
$1,348
$4.25 P/Share
|
|
Jan 26
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
227
+0.04%
|
$908
$4.24 P/Share
|
|
Jan 25
2023
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
9
+0.0%
|
$36
$4.25 P/Share
|
|
Jan 13
2023
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
504
+0.18%
|
$1,512
$3.88 P/Share
|
|
Jan 04
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,266
+0.16%
|
$3,798
$3.68 P/Share
|
|
Jan 03
2023
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,324
+0.29%
|
$6,972
$3.64 P/Share
|
|
Dec 30
2022
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
410
+0.05%
|
$1,230
$3.5 P/Share
|
|
Dec 30
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
500
+0.1%
|
$1,500
$3.5 P/Share
|
|
Dec 29
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
1,471
+0.29%
|
$4,413
$3.49 P/Share
|
|
Dec 28
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
1,266
+0.25%
|
$3,798
$3.41 P/Share
|
|
Dec 27
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
604
+0.12%
|
$1,812
$3.38 P/Share
|
|
Dec 23
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
981
+0.19%
|
$2,943
$3.45 P/Share
|
|
Dec 22
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
731
+0.14%
|
$2,193
$3.34 P/Share
|
|
Dec 21
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
399
+0.08%
|
$1,197
$3.43 P/Share
|
|
Dec 20
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
4,048
+0.79%
|
$12,144
$3.53 P/Share
|
|
Dec 07
2022
|
Sergei Gryaznov Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.34%
|
$10,000
$1.83 P/Share
|
|
Sep 13
2022
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
8,798
+2.87%
|
$26,394
$3.85 P/Share
|
|
Aug 30
2022
|
Ramiro Guerrero Director |
BUY
Open market or private purchase
|
Direct |
283
+0.1%
|
$849
$3.97 P/Share
|
|
Aug 24
2022
|
Sergei Gryaznov Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.47%
|
$10,000
$1.8 P/Share
|
|
Aug 01
2022
|
Stan Smith Director |
BUY
Other acquisition or disposition
|
Indirect |
7,200
+1.41%
|
-
|
|
Aug 01
2022
|
Stan Smith Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+28.73%
|
$1,000,000
$5.0 P/Share
|
|
Aug 01
2022
|
Mihail Obrocea Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+3.56%
|
$5,000
$5.0 P/Share
|
|
Aug 01
2022
|
Vlad Vitoc Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.75%
|
$30,000
$5.0 P/Share
|
|
Aug 01
2022
|
Joseph F Mcguire Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$25,000
$5.0 P/Share
|
|
Aug 01
2022
|
Laurentiu Vlad Director |
BUY
Open market or private purchase
|
Direct |
5,000
+1.31%
|
$25,000
$5.0 P/Share
|
|
Aug 01
2022
|
Cristian Luput Director |
BUY
Open market or private purchase
|
Direct |
500
+0.18%
|
$2,500
$5.0 P/Share
|
|
Aug 01
2022
|
Ngar Yee Louie Director |
BUY
Open market or private purchase
|
Direct |
20,000
+2.11%
|
$100,000
$5.0 P/Share
|
|
Aug 01
2022
|
Sergei Gryaznov Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+10.9%
|
$15,000
$5.0 P/Share
|
|
Aug 01
2022
|
Steven M Chaouki Director |
BUY
Other acquisition or disposition
|
Direct |
8,000
+12.85%
|
-
|